CalFeed Share & Discover Online Events
Online Events

Fri - Dec 11, 2009 @ 01:00 PM CST Ended
1
votes

Avoiding the 14 Biggest Mistakes Made by Emerging Life Science Companies in Reimbursement, Valuation, Investor Presentations and Regulatory Strategy

(www.windhover.com)

Reimbursement, Valuation, Investor Presentations, and Regulatory Strategy: This webinar covers each of these critical elements in life science company development, illustrating how making the right decisions early can ensure funding and avoid costly, time-consuming and some-times disastrous errors. Here’s some of what you’ll learn during this 90-minute webinar:

*

Where 168 lifescience VCs invest and how this information will allow you to target those who will say “yes”.
*

How to bracket your projections to develop a realistic story, even if you may not know the real numbers.
*

How paying attention to regulatory timeframes to secure new reimbursement can pay off in early product adoption.
*

How developing a pricing strategy that connects to the clinical or economic value of the technology can reap dividends on company valuation and commercialization.
*

How asking tough questions of your target market positively affects your funding potential.
*

10 must-include slides in your financial presentation to capture the confidence of investors.
*

A sure-fire method of presenting your prior, current, and future burn that will answer investors' critical questions.
*

How timeline to exit should be presented to set realistic expectations.
*

How having no competition can create an alarm in the investment community.
*

How using a technology superiority hypothesis in your pivotal trial can enhance your reimbursement prospects.
*

How investigating the potential reimbursement landscape early in product development can favorably impact product design, investor acceptance and commercialization.
*

How PMA approvals have become the preferred regulatory pathway for reimbursement decision-makers.
*

What gets lost in the commercialization process when it’s assumed that reimbursement comes automatically upon FDA clearance.
*

How recognizing that physicians, hospitals and insurers DON’T share the same financial motivations should influence every aspect of product development, from product design to valuation to commercialization.

For one low price, you and your entire team from one location can take part in this fast-paced, insightful webinar. Best of all, you’ll be able to connect personally with our panelists when we open up the phone lines for live Q&A. The discussion will be delivered in a convenient audio conference format, and capped off with an interactive Q&A round.

Tags

  • medical, health, healthcare, hospitals

Comments will remain editable for 15 minutes after posting.